VC DEALS ANALYSIS: October Levels Still Hold, Making November Beat Possible
This article was originally published in Clinica
The volume of medtech venture financing deals stayed buoyant going from September into October, but total deal value dipped slightly. That said, the gap between the total amount of venture dollars raised this year so far compared with 2014 has now narrowed to the extent that come the end of November, 2015’s takings will surpass that of last year.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.